Share
 
Title
Code
Session Type
Venue
Date Time
Co-Chairs:
11:00
TUAC0101
Oral administration of maraviroc, in infant rhesus macaques, fails to prevent SIVmac oral transmission
Egidio Brocca-Cofano, University of Pittsburgh, United States
Abstract
Slides

11:15
TUAC0102
HPTN 069/ACTG A5305: phase II study of maraviroc-containing regimens for HIV PrEP in United States (U.S.) women
Roy Gulick, Weill Cornell Medicine, United States
Abstract
Slides

11:30
TUAC0103
Persistence of rilpivirine following single dose of long-acting injection
Ian McGowan, University of Pittsburgh, United States
Abstract
Slides

11:45
TUAC0104
Benefits of pre-exposure prophylaxis relative to drug resistance risk
Robert Grant, Gladstone Institutes, United States
Abstract
Slides

12:00
TUAC0105LB
Residual dapivirine ring levels indicate higher adherence to vaginal ring is associated with HIV-1 protection
Elizabeth Brown, Fred Hutchinson Cancer Research Center, United States
Abstract
Slides

12:15
TUAC0106
Moderated discussion